Adaptix Imaging
Adaptix Imaging
Adaptix is transforming planar X-ray by giving it true 3D capability, making it safer by reducing dose (versus CT, and potentially versus planar X-ray), making the systems 50% cheaper than existing market offerings and reducing weight and size by 90%. By doing this we will be improving access to the world’s most important medical diagnostic device and radically changing a £5bn global market.
Phone: 01865 309619
www.Adaptiximaging.com
Chiralabs
Chiralabs
Chiralabs provides specialist consultancy, research and analytical services for investigating molecular products in the pharmaceutical, biotechnology and chemical industries. Chiralabs has been at BSP since 2006 and has customers across the site.
Phone: 01865 854810
www.chiralabs.biz
Oxford Gene Technology (OGT)
Oxford Gene Technology (OGT)
Molecular genetics company delivering solutions to leading clinical and academic research institutions. Founded by Professor Sir Edwin Southern in 1995, OGT has an increasing share of the expanding genomic medicine market with customers in over 60 countries worldwide.
Phone: +44 1865 856800
Website: www.ogt.co.uk
Population Bio UK
Population Bio UK
Population Bio UK applies discoveries in human genetics to the development of DNA-based diagnostics and personalised medicine tests.
Phone: +44 7825 408322
Website: www.populationbio.com
Environmental Biotechnology
Environmental Biotechnology
Contact: Professor Ian Thompson
Webpage (Personal)
Website (Group)
Telephone: +44 1865 283789
Ian Thompson investigates the role of micro-organisms including the development of bioreactors for treating industrial effluent, metal recovery and water recycling, and exploitation of microbial-nanomaterial interactions for killing water-borne pathogens.
Nanoparticles for Cancer Therapy
Nanoparticles for Cancer Therapy
Contact: Dr Helen Townley
Webpage: (Personal)
Telephone: +44 1865 283792
This interdisciplinary group, involving the Nuffield Department of Obstetrics and Gynaecology and nanoscientists from the Department of Engineering Science, led by Dr Helen Townley, focuses on the use of nanoparticles in cancer therapy, imaging or drug delivery.